Novel therapies tailored to the molecular composition of esophageal squamous cell carcinoma (ESCC) are needed to improve patient survival. We investigated the regulatory network of long intergenic non-protein ...
from Cancer via ola Kala on Inoreader http://ift.tt/2Cf2KBU
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου